Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells

被引:39
|
作者
Mahyar-Roemer, M
Fritzsche, C
Wagner, S
Laue, M
Roemer, K
机构
[1] Univ Saarland, Sch Med, Dept Virol, D-66421 Homburg, Germany
[2] Univ Saarland, Sch Med, Dept Anat & Cell Biol, Ctr Electron Microscopy, D-66421 Homburg, Germany
关键词
tumor suppressor; p53; mitochondria; apoptosis;
D O I
10.1038/sj.onc.1207637
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 can eliminate damaged cells through the induction of mitochondria-mediated apoptosis. Recent observations have provided strong evidence that a fraction of total p53 translocates to mitochondria specifically in response to a death stimulus. Unexpectedly, mutant p53, which is expressed at much higher levels than wild type in unstressed cells, is apparently always present at the mitochondria, independent of apoptotic signal. This prompted us to ask whether cell lines with intact p53-dependent apoptosis and cell cycle arrest pathways exist in which the mitochondrial localization of wild-type p53, like that of mutant, is independent of a death stimulus and instead, correlates with the total p53 levels. Here, we document that human HCT116 colorectal carcinoma cells treated with adriamycin or 5-fluorouracil (5FU) can accumulate total p53 to equally high levels, and mitochondrial p53 to proportionate levels, although only 5FU treatment provoked p53-dependent apoptosis. Along the same line, HCT116 derivatives with increased basal p53 levels, and glioblastoma cells with a doxycycline-inducible p53, also revealed proportionate mitochondrial p53 levels, and even unstressed HCT116 cells had some p53 located at the mitochondria. Finally, mitochondrial and total p53 showed distinct post-translational modi. cations. Thus, cell lines exist in which the mitochondrial p53 levels parallel total levels independent of apoptosis.
引用
收藏
页码:6226 / 6236
页数:11
相关论文
共 50 条
  • [41] P53 ABNORMALITIES IN HUMAN PARATHYROID CARCINOMA
    CRYNS, VL
    RUBIO, MP
    THOR, AD
    LOUIS, DN
    ARNOLD, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (06): : 1320 - 1324
  • [42] Prognostic value of p53 protein in colorectal carcinoma
    Diez, M
    Gutiérrez, A
    López, A
    Martínez, P
    Hernandez, P
    Martín, A
    Mugüerza, JM
    Villeta, R
    Ruiz, A
    Noguerales, F
    Granell, J
    BRITISH JOURNAL OF SURGERY, 1998, 85 : 1 - 1
  • [43] The p53 response: Emerging levels of co-factor complexity
    Coutts, AS
    La Thangue, NB
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (03) : 778 - 785
  • [44] p53 autoantibodies in sera of patients with a colorectal cancer and their association to p53 protein concentration and p53 immunohistochemistry in tumor tissue
    R. Broll
    M. Duchrow
    E. Oevermann
    C. Wellm
    O. Schwandner
    H. Schimmelpenning
    U.J. Roblick
    H.P. Bruch
    U. Windhövel
    International Journal of Colorectal Disease, 2001, 16 : 22 - 27
  • [45] p53 autoantibodies in sera of patients with a colorectal cancer and their association to p53 protein concentration and p53 immunohistochemistry in tumor tissue
    Broll, R
    Duchrow, M
    Oevermann, E
    Wellm, C
    Schwandner, O
    Schimmelpenning, H
    Roblick, UJ
    Bruch, HP
    Windhövel, U
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2001, 16 (01) : 22 - 27
  • [46] p53 and stress in the ER
    Stavridi, ES
    Halazonetis, TD
    GENES & DEVELOPMENT, 2004, 18 (03) : 241 - 244
  • [47] Profiling inhibitors of MDM2: p53 and MDMX: p53 in relation to MDMX protein levels
    Tudhope, Sue
    Zhao, Yan
    Wittner, Anita
    Wilmore, Elaine
    Bertoli, Annalisa
    Adhikari, Santosh
    Harnor, Suzannah J.
    Del Bello, Fabio
    Piergentili, Alessandro
    Lunec, John
    Hardcastle, Ian R.
    Griffin, Roger J.
    Golding, Bernard R.
    Cano, Celine
    Newell, David R.
    Wedge, Stephen R.
    CANCER RESEARCH, 2014, 74 (19)
  • [48] The human cytomegalovirus IE2 86 kDa protein elevates p53 levels and transactivates the p53 promoter in human fibroblasts
    Muganda, P
    Carrasco, R
    Qian, QB
    CELLULAR AND MOLECULAR BIOLOGY, 1998, 44 (02) : 321 - 331
  • [49] PUMA mediates the apoptotic response to p53 in colorectal cancer cells
    Yu, J
    Wang, ZH
    Kinzler, KW
    Vogelstein, B
    Zhang, L
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) : 1931 - 1936
  • [50] Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents
    Michaelis, M.
    Rothweiler, F.
    Agha, B.
    Barth, S.
    Voges, Y.
    Loeschmann, N.
    von Deimling, A.
    Breitling, R.
    Doerr, H. Wilhelm
    Roedel, F.
    Speidel, D.
    Cinatl, J., Jr.
    CELL DEATH & DISEASE, 2012, 3 : e294 - e294